Vulnerability in Becton Dickinson & Co Bd Bactec™ Blood Culture System
CVE-2024-10476
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.0 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.002 (13.1th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 13th percentile — 13.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: -0.000
Affected products
- Becton Dickinson & Co Bd Bactec™ Blood Culture System — versions 0
- Becton Dickinson & Co Bd Cor™ System — versions 0
- Becton Dickinson & Co Bd Epicenter™ Microbiology Data Management System — versions 0
- Becton Dickinson & Co Bd Max™ System — versions 0
- Becton Dickinson & Co Bd Phoenix™ M50 Automated Microbiology System — versions 0
- Becton Dickinson & Co Bd Synapsys™ Informatics Solution — versions 0
Weakness classification (CWE)
References
Frequently asked questions
- What is CVE-2024-10476?
- CVE-2024-10476 is a high-severity vulnerability in Becton Dickinson & Co Bd Bactec™ Blood Culture System, classified under CWE-1392. CVSS score: 8.0/10. Published 2024-12-17.
- How severe is CVE-2024-10476?
- High severity. CVSS v3 base score is 8.0 out of 10.